Expression of the DMBT1 gene is frequently suppressed in human lung cancer

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 903-908

  Takeshita, Hiroaki ^a,d   Sato, Masami ^a,b   Shiwaku, Hiromi O ^a   Semba, Shuho ^a   Sakurada, Akira ^a,b   Hoshi, Masato ^a   Hayashi, Yutaka ^a   Tagawa, Yutaka ^c   Ayabe, Hiroyoshi ^d   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromosome 10q; DMBT1; Human lung cancer; SRCR family

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 10Q; CONTROLLED STUDY; EXON; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE MAPPING; GENE REARRANGEMENT; GENE REPRESSION; GENE STRUCTURE; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0032707132     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00833.x     Document Type: Article

References (31)

1. Petersen, I., Bujard, M., Petersen, S., Wolf, G., Goeze, A., Schwendel, A., Langreck, H., Gellert, K., Reichel, M., Just, K., du Manoir, S., Cremer, T., Dietel, M. and Ried, T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res., 57, 2331-2335 (1997).
2. Balsara, B. R., Sonoda, G., du Manoir, S., Siegfried, J. M., Gabrielson, E. and Testa, J. R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res., 57, 2116-2120 (1997).
3. Todd, S., Franklin, W. A., Varella-Garcia, M., Kennedy, T., Hilliker, C. E., Jr., Hahner, L., Anderson, M., Wiest, J. S., Drabkin, H. A. and Gemmill, R. M. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res., 57, 1344-1352 (1997).
4. Wiest, J. S., Franklin, W. A., Otstot, J. T., Forbey, K., Varella-Garcia, M., Rao, K., Drabkin, H., Gemmill, R., Ahrent, S., Sidransky, D., Saccomanno, G., Fountain, J. W. and Anderson, M. W. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res., 57, 1-6 (1997).
5. Fong, K. M., Zimmerman, P. V. and Smith, P. J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res., 55, 220-223 (1995).
6. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H. and Yokota, J. Frequent allelic losses on chromosome 2q, 18q, and 22q in advanced non-small cell carcinoma. Cancer Res., 54, 5643-5648 (1994).
7. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B. and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54, 2322-2326 (1994).
8. Ried, T., Petersen, I., Holtgreve-Grez, H., Speicher, M. R., Schrock, E., du Manoir, S. and Cremer, T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res., 54, 1801-1806 (1994).
9. Sato, M., Mori, Y., Sakurada, A., Fukushige, S., Ishikawa, Y., Tsuchiya, E., Saito, Y., Nukiwa, T., Fujimura, S. and Horii, A. Identification of a 910 kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Genes Chromosom. Cancer, 22, 1-8 (1998).
10. Petersen, S., Rudolf, J., Bockmuhl, U., Gellert, K., Wolf, G., Dietel, M. and Petersen, I. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung. Oncogene, 17, 449-454 (1998).
11. Petersen, S., Wolf, G., Bockmuhl, U., Gellert, K., Dietel, M. and Petersen, I. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br. J. Cancer, 77, 270-276 (1998).
12. Li, D. M. and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res., 57, 2124-2129 (1997).
13. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
14. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F. and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15, 356-362 (1997).
15. Kong, D., Suzuki, A., Zou, T.-T., Sakurada, A., Kemp, L. W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M., Ohuchi, N., Sato, S., Yin, J., Wang, S., Abraham, J. M., Souza, R. F., Smolinski, K. N., Meltzer, S. J. and Horii, A. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet., 17, 143-144 (1997).
16. Risinger, J. I., Hayes, A. K., Berchuck, A. and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57, 4736-4738 (1997).
17. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940 (1997).
18. Levine, R. L., Cargile, C. B., Blazes, M. S., van Rees, B., Kurman, R. J. and Ellenson, L. H. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res., 58, 3254-3258 (1998).
19. Maxwell, G. L., Risinger, J. I., Gumbs, C., Shaw, H., Bentley, R. C., Barrett, J. C., Berchuck, A. and Futreal, P. A. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res., 58, 2500-2503 (1998).
20. Yoshinaga, K., Sasano, H., Furukawa, T., Yamakawa, H., Yuki, M., Sato, S., Yajima, A. and Horii, A. The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn. J. Cancer Res., 89, 985-990 (1998).
21. Sakurada, A., Suzuki, A., Sato, M., Yamakawa, H., Orikasa, K., Uyeno, S., Ono, T., Ohuchi, N., Fujimura, S. and Horii, A. Infrequent genetic alterations of the PTEN/ MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn. J. Cancer Res., 88, 1025-1028 (1997).
22. Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A. and Poustka, A. DMBT1, a new member of the SRCR super-family, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet., 17, 32-39 (1997).
23. Law, S. K. A., Micklem, K. J., Shaw, J. M., Zhang, X. P., Dong, Y., Willis, A. C. and Mason, D. Y. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur. J. Immunol., 23, 2320-2325 (1993).
24. Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., Dreps, A., Azam, M., Rubinstein, M., Natoli, C., Shawver, L. K., Schlessinger, J. and Iacobelli, S. The secreted tumor-associated antigen 90K is a potent immune stimulator. J. Biol. Chem., 269, 18401-18407 (1994).
25. Whitney, G. S., Starling, G. C., Bowen, M. A., Modrell, B., Siadak, A. W. and Aruffo, A. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J. Biol. Chem., 270, 18187-18190 (1995).
26. Starling, G. C., Whitney, G. S., Siadak, A. W., Llewellyn, M. B., Bowen, M. A., Farr, A. G. and Aruffo, A. A. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur. J. Immunol., 26, 738-746 (1996).
27. Al-Awqati, Q. Plasticity in epithelial polarity of renal intercalated cells: targeting of the H(+)-ATPase and band 3. Am. J. Physiol, 270, C1571-1580 (1996).
28. Bork, P. and Sander, C. A large domain common to sperm receptors (Zp2 and Zp3) and TGF-beta type III receptor. FEBS Lett., 300, 237-240 (1992).
29. Sun, L. and Chen, C. Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J. Biol. Chem., 272, 25367-25372 (1997).
30. Mori, Y., Shiwaku, H., Fukushige, S., Wakatsuki, S., Sato, M., Nukiwa, T. and Horii, A. Alternative splicing of hMSH2 in normal human tissues. Hum. Genet., 99, 590-595 (1997).
31. Wu, W., Kemp, B. L., Proctor, M. L., Gazdar, A. F., Minna, J. D., Hong, W. K. and Mao, L. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res., 59, 1846-1851 (1999).